{"id":19039,"date":"2021-10-29T08:00:09","date_gmt":"2021-10-29T12:00:09","guid":{"rendered":"https:\/\/medicarereport.org\/?p=19039"},"modified":"2021-10-29T08:00:09","modified_gmt":"2021-10-29T12:00:09","slug":"a-cheap-antidepressant-is-showing-promise-treating-covid-19-in-high-risk-adults","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=19039","title":{"rendered":"A cheap antidepressant is showing promise treating COVID-19 in high-risk adults"},"content":{"rendered":"<p>(NPR)<\/p>\n<p>A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.<\/p>\n<p>Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.\u00a0 Continue reading the article <a href=\"https:\/\/www.npr.org\/2021\/10\/28\/1050202177\/antidepressant-fluvoxamine-covid-19-treatment\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3902\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" width=\"152\" height=\"55\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 152px) 100vw, 152px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(NPR) A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[52,15],"tags":[],"class_list":["post-19039","post","type-post","status-publish","format-standard","hentry","category-pandemic","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19039"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19039\/revisions"}],"predecessor-version":[{"id":19040,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19039\/revisions\/19040"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}